- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Morgan Stanley Upgrades Accenture (ACN) to Overweight, Raises Target to $320 | ||
| Fr | CrowdStrike's (CRWD) Market Leadership Supports Premium, Citizens Says | ||
| Fr | Canaccord Maintains Buy on Rivian (RIVN) After Autonomy & AI Day | ||
| Fr | KeyBanc Turns Bearish on Adobe (ADBE) Despite Strong Q4 Results | ||
| Fr | ServiceNow (NOW) Stock Downgraded on Structural AI Concerns, KeyBanc Says | ||
| Fr | Nvidia's (NVDA) Long-Term AI Leadership Intact, Says Bernstein | ||
| Fr | Raymond James Initiates MongoDB (MDB) at Market Perform, Flags AI Crossroads | ||
| Fr | Piper Sandler Reiterates Overweight on AMD, Sees AI Catalysts Ahead | ||
| Fr | Mizuho Raises Tesla Price Target to $530, Backs Robotaxi Momentum | ||
| Fr | 10 Firms Stealing the Show on Wall Street | ||
| Fr | BMO Keeps Outperform on Amazon (AMZN), Sees AWS Growth Accelerating | ||
| Fr | Cantor Keeps Overweight on AMD Despite Target Cut, Citing Strong AI Tailwinds | ||
| Fr | Eli Lilly (LLY) Gains Support From Daiwa and Goldman Sachs in Back-to-Back Calls | ||
| Fr | BTIG Initiates ServiceNow (NOW) with Buy Rating on Expanding AI Platform | ||
| Fr | Phillip Maintains Buy on Adobe (ADBE), Sees Steady Growth Into FY26 | ||
| Fr | Workday (WDAY) Earns Buy Rating as BTIG Calls Outlook "De-Risked" | ||
| Fr | Goldman, Barclays Lower Roper (ROP) Price Targets Amid Muted End-Market Expectations | ||
| Fr | BofA Adjusts Elevance Health (ELV) Target to Reflect Higher Sector Valuations | ||
| Fr | BofA Raises Analog Devices (ADI) Target, Sees Long AI-Driven Upgrade Cycle Ahead | ||
| Fr | JPMorgan Reinstates Palo Alto Networks (PANW) With Overweight Rating | ||
| Do | Hedge Fund and Insider Trading News: Bill Ackman, Warren Buffett, Steve Cohen, Citadel Investment Group, Elliott Management, Altai Capital, Elanco Animal Health Inc (ELAN), NVIDIA Corp (NVDA), and More | ||
| Do | Capricor Therapeutics, Inc. (CAPR): A Bear Case Theory | ||
| Do | McDonald's Corporation (MCD): A Bull Case Theory | ||
| Do | Moderna, Inc. (MRNA): A Bull Case Theory | ||
| Do | Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .